Boehringer Ingelheim Nexgard Dog Tick and Flea Control Tablet,3 tablets
Give your dog the protection it deserves with Boehringer Ingelheim Nexgard—a vet-recommended, chewable tablet designed to eliminate and prevent tick and flea infestations, Boehringer Ingelheim Nexgard perfect for dogs weighing between 2–50 kg, Nexgard offers monthly protection with a deliciously flavored chew that dogs love, whether you have a tiny pup or a large breed, this Boehringer Ingelheim Nexgard solution provides comprehensive defense against parasites that cause discomfort and transmit diseases like Lyme.
Composition: AFOXOLANER.
Key Benefits & Features of Boehringer Ingelheim Nexgard
-
Fast-Acting & Long-Lasting Protection
Starts killing fleas within 30 minutes and ticks within 4 hours, lasting for a full month. - Kills Fleas. Ticks & Mites
Kills fleas, ticks, and mites efficiently, preventing infestations. - Prevent Tick-Borne Diseases
Prevents Lyme disease, Ehrlichiosis, and Anaplasmosis caused by tick bites. -
Easy-to-Give Chewable Tablet
Palatable flavored chew is easy to administer without food restrictions. -
Vet-Recommended & Trusted Globally
Clinically proven and widely used by veterinarians for its safety and efficacy. -
Effective for All Breeds and Sizes
Available in weight-specific packs: 2–4 kg, 4–10 kg, 10–25 kg, and 25–50 kg. -
Kills Before They Can Lay Eggs
Prevents future infestations by eliminating parasites before they reproduce.
Dosage Chart & Instructions for Boehringer Ingelheim Nexgard
Dog Weight (kg) | Nexgard Variant | Dosage Frequency | Tablet Strength (mg) |
---|---|---|---|
2 – 4 kg | Nexgard for Small Dogs | Once every month | 11.3 mg |
4 – 10 kg | Nexgard for Small Dogs | Once every month | 28.3 mg |
10 – 25 kg | Nexgard for Medium Dogs | Once every month | 68 mg |
25 – 50 kg | Nexgard for Large Dogs | Once every month | 136 mg |
Directions for Use:
Administer one tablet orally once a month of Boehringer Ingelheim Nexgard, no need to administer with food, but can be given with meals if preferred, ensure your dog consumes the full dose, always consult your vet for the right dosage, especially for puppies or dogs over 50 kg (a combination of tablets may be recommended).
Storage & Precautions
-
Store in a cool, dry place below 30°C
-
Keep out of reach of children and other pets
-
For animal use only; not intended for human consumption
-
Do not use in dogs with a known history of seizures without veterinary advice
-
Use only in dogs 8 weeks of age and older, weighing at least 2 kg
-
Wash hands thoroughly after handling
Product Details
-
Brand: Boehringer Ingelheim
-
Product Type: Oral Tick & Flea Control Tablet
-
Target Species: Dogs
-
Pack Size/Form: 3 Chewable Tablets
-
Weight Ranges: Available for 2–4 kg, 4–10 kg, 10–25 kg, 25–50 kg
-
Active Ingredient: Afoxolaner
-
Flavor: Flavored chew
-
Application Frequency: Monthly
Disclaimer: The information provided on Petmedicine.co is intended solely for educational and informational purposes. While we endeavor to ensure that all content is accurate, evidence-based, and reviewed by qualified professionals, it is not a substitute for professional veterinary advice, diagnosis, or treatment. This website does not provide medical advice, and any reliance on the information presented herein is at the user’s own risk. The content may not cover all possible conditions, diagnostic procedures, medications, side effects, interactions, or treatment precautions. Users are strongly advised to consult a licensed veterinarian for any concerns regarding the health, diagnosis, or treatment of their pets. Petmedicine.co does not intend to establish a veterinarian-client-patient relationship.
Disclosure: All medication orders placed through Petmedicine.co are processed by our in-house pharmacy. Upon receipt of your order it will be dispatched in accordance with applicable regulations. For prescription medications, our in-house licensed pharmacist or veterinarian may contact you to verify the prescription and confirm the appropriateness of the medication for your pet.
Reviews
There are no reviews yet.